These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14697146)

  • 21. [Liver cirrhosis: pathogenesis of ascites and disturbance of renal function].
    Toledo C; Ginés P; Arroyo V
    Rev Med Chil; 1992 Feb; 120(2):180-7. PubMed ID: 1340557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of plasma endotoxin levels in patients with cirrhosis.
    Chan CC; Hwang SJ; Lee FY; Wang SS; Chang FY; Li CP; Chu CJ; Lu RH; Lee SD
    Scand J Gastroenterol; 1997 Sep; 32(9):942-6. PubMed ID: 9299675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial serum procalcitonin changes in the prognosis of acute stroke.
    Miyakis S; Georgakopoulos P; Kiagia M; Papadopoulou O; Pefanis A; Gonis A; Mountokalakis TD
    Clin Chim Acta; 2004 Dec; 350(1-2):237-9. PubMed ID: 15530484
    [No Abstract]   [Full Text] [Related]  

  • 25. [Procalcitonin in pediatric resuscitation].
    Leclerc F; d'Herbomez M
    Arch Pediatr; 2004 Jun; 11(6):587-9. PubMed ID: 15158844
    [No Abstract]   [Full Text] [Related]  

  • 26. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Procalcitonin as an indicator of infection in patients with liver cirrhosis].
    Husová L; Husa P; Senkyrík M; Lata J
    Vnitr Lek; 2004 Feb; 50(2):153-6. PubMed ID: 15077592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute influence of aerobic physical exercise on procalcitonin.
    Lippi G; Schena F; Montagnana M; Salvagno GL; Guidi GC
    Eur J Clin Invest; 2008 Oct; 38(10):784-5. PubMed ID: 18837805
    [No Abstract]   [Full Text] [Related]  

  • 29. The 'overflow' theory of ascites formation: a fading concept?
    Henriksen JH
    Scand J Gastroenterol; 1983 Oct; 18(7):833-7. PubMed ID: 6374865
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery.
    Amour J; Birenbaum A; Langeron O; Le Manach Y; Bertrand M; Coriat P; Riou B; Bernard M; Hausfater P
    Crit Care Med; 2008 Apr; 36(4):1147-54. PubMed ID: 18379240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.
    Llach J; Ginès P; Arroyo V; Rimola A; Titó L; Badalamenti S; Jiménez W; Gaya J; Rivera F; Rodés J
    Gastroenterology; 1988 Feb; 94(2):482-7. PubMed ID: 3335320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin measurement for differential diagnosis between pulmonary embolism and pneumonia.
    Delèvaux I; André M; Aumaître O; Bègue RJ; Colombier M; Piette JC
    Crit Care Med; 2003 Feb; 31(2):661. PubMed ID: 12576992
    [No Abstract]   [Full Text] [Related]  

  • 34. The Negative Prognostic Impact of a First Ever Episode of Spontaneous Bacterial Peritonitis in Cirrhosis and Ascites.
    Ra G; Tsien C; Renner EL; Wong FS
    J Clin Gastroenterol; 2015; 49(10):858-65. PubMed ID: 25811112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
    Lo GH; Lam HC; Cheng JT; Lin JK; Hsu JH; Lai KH; Chiang HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):596-602. PubMed ID: 9830237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Procalcitonin in invasive candidosis].
    Jemli B; Aouni Z; Lebben I; Mazigh C; Ferjani M; Machgoul M; Gargouri S
    Ann Biol Clin (Paris); 2007; 65(2):169-73. PubMed ID: 17353171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of procalcitonin at the pediatric emergency room].
    Gendrel D
    Arch Pediatr; 2004 Jun; 11(6):582-4. PubMed ID: 15158842
    [No Abstract]   [Full Text] [Related]  

  • 38. Severity and prognostic assessment of the endotoxin activity assay in biliary tract infection.
    Sato M; Matsuyama R; Kadokura T; Mori R; Kumamoto T; Nojiri K; Taniguchi K; Takeda K; Kubota K; Tanaka K; Endo I
    J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):120-7. PubMed ID: 23798326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endotoxins in chronic heart failure.
    Brunkhorst FM
    Lancet; 1999 Aug; 354(9178):599-600. PubMed ID: 10470730
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites.
    Wong F; Bomzon A; Allard J; Liu P; Blendis L
    Clin Sci (Lond); 1999 May; 96(5):467-74. PubMed ID: 10209078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.